Expedient routes to a tritiated derivative of the v-sis oncogene-transformed cell specific growth inhibitor 3-azido-3-deoxy-myo-inositol and the unlabelled 2,4,5-trisphosphate derivative are described together with the effects of the latter compound in binding to the IP3 receptor.
|Original language||English (US)|
|Number of pages||3|
|Journal||Journal of the Chemical Society, Chemical Communications|
|State||Published - Dec 1 1992|
ASJC Scopus subject areas
- Molecular Medicine